Global Cardiovascular Digital Solutions Market is valued at approximately USD 97.52 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.80% over the forecast period 2022-2029. Cardiovascular digital solutions are the fusion and application of digital technologies such as software, wearables, sensors, smartphones, artificial intelligence, and virtual healthcare solutions. To develop and offer effective healthcare solutions, digital healthcare systems are being used. The Cardiovascular Digital Solutions Market is expanding because of factors such as the rising prevalence of cardiovascular diseases and rapid advancement in healthcare technology.

One of the key factors fueling the growth of the market for cardiovascular digital solutions is the quick digitalization of the healthcare industry globally. The rise in the comorbidity of CVD with other medical conditions and disease states, necessitating multi-parameter monitoring beyond the ECG to make cardiac care more targeted and effective, is driving up demand for digital solutions, which is driving the growth of the cardiovascular digital solutions market. According to a Future Science Group report, 7.6 million diagnosed instances of chronic heart failure (CHF) and an estimated 3.6 million heart failure hospitalizations were expected in North America in 2020. Along with these, according to a report on the "Epidemiological Features of Cardiovascular Disease in Asia" published in JACC journals, cardiovascular disease (CVD) continues to be the main cause of fatalities and preventable deaths globally. Asia accounted for almost 58% of the 18.6 million CVD deaths that occurred worldwide in 2019. Furthermore, the rising geriatric population is also leveraging market growth. According to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. In addition, Research and development initiatives, improved healthcare infrastructure, and an increase in healthcare spending all have a beneficial impact on the market for cardiovascular digital solutions.

The key regions considered for the Global Cardiovascular Digital Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded Service Types and the region’s increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
iRythm Technologies, Inc.
Apple Inc.
General Electric Company
Uber Diagnostics Pvt Ltd
AlivCor, Inc.
Verily Life Sciences LLC
HeartFlow, Inc.
Bardy Diagnostics, Inc.
Bio Telemetry, Inc.
Koninkelijke Philips N.V

Recent Developments in the Market:
? In April 2022, Medtronic, a manufacturer of medical devices, and GE Healthcare, a supplier of medical technology, collaborated. The goal of the collaboration was to concentrate on the significant demand for care at ambulatory surgery centres (ASCs) and office-based labs (OBLs). Customers can access broad product portfolios, financial solutions, and other great services through this relationship.
? In March 2022, Philips announced the launch of the ACC 2022 workspace which facilitates echocardiography technique. Cardiologists may employ a standardised set of AI-driven medical imaging and quantification tools both on and off the echocardiography cart to aid increase efficiency and uniformity while also improving diagnostic precision.

Global Cardiovascular Digital Solutions Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Service Type, Deployment, Component, End Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Service Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Service Type:
Unobtrusive Testing
CVD Health Informatics
Cardiac Rehab Programs

By Deployment:
By component:
By End Use:
Hospitals & Clinics
Ambulatory care centers

By Region:
North America
Asia Pacific
South Korea
Latin America
Rest of the World